Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma. | Sci Rep | 2023 | 37072493 | PubTator, text mining | PubMed |
| The diverse role of RNA methylation in esophageal cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37070847 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
| The Proteins of mRNA Modification: Writers, Readers, and Erasers. | Annu Rev Biochem | 2023 | 37068770 | PubTator, text mining | PubMed |
| YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer. | J Thorac Dis | 2023 | 37065597 | PubTator, text mining | PubMed |
| Integrative Genomic Analysis of m6a-SNPs Identifies Potential Functional Variants Associated with Alzheimer's Disease. | ACS Omega | 2023 | 37065064 | PubTator, text mining | PubMed |
| Bibliometric and visual analysis of RAN methylation in cardiovascular disease. | Front Cardiovasc Med | 2023 | 37063953 | PubTator, text mining | PubMed |
| Novel insights into the interplay between m6A modification and programmed cell death in cancer. | Int J Biol Sci | 2023 | 37063421 | PubTator, text mining | PubMed |
| The m6A-regulation and single cell effect pattern in sunitinib resistance on clear cell renal cell carcinoma: Identification and validation of targets. | Front Pharmacol | 2023 | 37063301 | PubTator, text mining | PubMed |
| Construction of an RNA modification-related gene predictive model associated with prognosis and immunity in gastric cancer. | BMC Bioinformatics | 2023 | 37061682 | PubTator, text mining | PubMed |
| m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition. | Cancer Lett | 2023 | 37061119 | PubTator, text mining | PubMed |
| Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37058053 | PubTator, text mining | PubMed |
| IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation. | Int J Biol Sci | 2023 | 37056932 | PubTator, text mining | PubMed |
| Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy. | Biomark Res | 2023 | 37055798 | PubTator, text mining | PubMed |
| N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication. | PLoS Pathog | 2023 | 37053288 | PubTator, text mining | PubMed |
| Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease. | Front Genet | 2023 | 37051599 | PubTator, text mining | PubMed |
| Targeted Demethylation of the TGFβ1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway. | Cells | 2023 | 37048078 | PubTator, text mining | PubMed |
| Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma. | Int J Mol Sci | 2023 | 37047493 | PubTator, text mining | PubMed |
| Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-β/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive Review. | Int J Mol Sci | 2023 | 37047394 | PubTator, text mining | PubMed |
| Potential Roles of m6A and FTO in Synaptic Connectivity and Major Depressive Disorder. | Int J Mol Sci | 2023 | 37047192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=61